Pioneering a Novel Disease-Modifying Therapy for Obstructive Lung DiseaseContinue reading
Author Archive: AZBioPEERS Team
Arizona Startup Leaders Form Arizona Venture Alliance
Arizona Venture Alliance to position the state as a premier location for startups and investorsContinue reading
AZBio Network: RESI Boston Partnering Opens Aug 19 – Register Today to Save $300!
Life Science Nation’s Redefining Early Stage Investments (RESI) conferences is a global conference series is a unique opportunity to connect early-stage life science companies with investors and strategic partners.
RESI Boston will bring 300+ early-stage life science investors and strategic partners who are actively looking to invest. RESI Boston is a can’t miss event for CEO’s looking to expand their network, gain company exposure, and schedule qualified meetings with potential capital partners. Sectors include R&D services, AI, digital health, medical technology, diagnostics, and therapeutics.Continue reading
Applications Due April 1 for 2024 MWU Health Careers Institute for High School Students
Join Midwestern University faculty and students for a FREE 8-day hands-on workshop for Arionhigh school students to learn about healthcare professions. Apply Here.
The Flinn-Brown Fellowship application is open: Apply Now!
The Flinn-Brown Fellowship is a statewide civic leadership program like no other. Apply here now.Continue reading
The University of Arizona Incubator Network Collaborates with Spencer Fane to Sponsor Startup Success
TUCSON, AZ. — The University of Arizona Center for Innovation (UACI) is pleased to announce the UACI Sponsored Launch Fueled by Spencer Fane LLP competition providing the winning startup team with resources, facilities, services and expert guidance to grow their business.Continue reading
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
Acquisition Would Create a More Vertically Integrated Company, Bringing Direct Responsibility for Supply Chain and Seed Manufacturing along with Perspective Therapeutic’s Cesium-131 Brachytherapy BusinessContinue reading
First Patient Enrolled in the PUERTA Phase 2A ARDS Clinical Trial: Treatment with Aqualung Therapeutics ALT-100 mAb
- A total of 14 PUERTA participating sites, 12 US and 2 Australian, in the Phase 2A trial of ALT-100 mAb in moderate to severe ARDS
- Aqualung awarded a $3M NIH R44 grant supporting the PUERTA Phase 2A Clinical Trial
Opportunity Alert: Traction Accelerator (Apply by December 15th)
Are you an entrepreneur ready to grow your revenue? Join the Traction Accelerator and get the tools, training, and community you need to rapidly grow your business.
The Traction Accelerator is a 19-week intensive program with 7 months of mentoring that will help you identify your ideal customers, craft messaging that converts, build sales systems that scale, and create momentum for your startup.
You’ll get access to top-tier mentors, and a network of like-minded founders facing similar challenges. Walk away with a clear plan to acquire customers and generate revenue. CEI is so confident this program will accelerate your startup’s growth that if you complete the program and don’t increase your revenue, they’ll refund your money.
Applications for Traction Accelerator close December 15th!
Learn more and apply here: ceigateway.com/traction-accelerator/
For additional information, contact Patti DuBois at dubois@ceigateway.com